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Proliferating Cell Nuclear Antigen (PCNA) ubiquitylation plays a crucial role in maintaining genomic
stability during DNA replication. DNA damage stalling the DNA replication fork induces PCNA ubiq-
uitylation that activates DNA damage bypass to prevent the collapse of DNA replication forks that
could potentially produce double-strand breaks and chromosomal rearrangements. PCNA ubiquity-
lation dictates the mode of bypass depending on the level of ubiquitylation; monoubiquitylation
and polyubiquitylation activate error-prone translesion synthesis and error-free template switch-
ing, respectively. Due to the error-prone nature of DNA damage bypass, PCNA ubiquitylation needs
to be tightly regulated. Here, we review the molecular mechanisms to remove ubiquitin from PCNA
including the emerging role of USP1 and ELG1 in this fascinating process.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Protein ubiquitylation is a reversible, 76 amino acid post-
translational modiﬁcation carried out by the coordinated activites
of an E1 ubiquitin-activating enzyme, an E2 ubiquitin conjugase,
and an E3 ubiquitin ligase. In the ﬁrst step of the ubiquitylation
reaction, ubiquitin is activated in an ATP-dependent process in
which a ubiquitin-adenylate intermediate is formed and ubiquitin
is transferred to a cysteine residue in the E1 active site, resulting in
a thioester linkage between the C-terminal carboxyl group of ubiq-
uitin and the E1 cysteine sulfydral group. Ubiquitin is then trans-
ferred to an E2 via a trans(thio)esteriﬁcation reaction. Finally, an
E3 binds to both the ubiquitin-carrying E2 and the substrate, and
catalyzes the formation of an isopeptide bond between a lysine
of the target protein and the C-terminal glycine of ubiquitin. Pro-
tein ubiquitylation plays an important role in the regulation of
many biological processes including protein stability, cell cycle
progression, apoptosis, growth signal transduction, transcriptional
regulation, endocytosis, vesicle trafﬁcking, and the DNA damage
response [1]. The functional consequence of a particular ubiquitin
moiety is dictated by the length of the ubiquitin chain as well as
the linkage type. For example, lysine 48 (K48)-linked polyubiquitin
chains mainly mark proteins for proteolysis, whereas lysine 164lf of the Federation of European Bi
.(K164)-linked monoubiquitylation triggers different cellular pro-
cesses including DNA repair [2].
Opposing the activities of the E1/E2/E3 ubiquitylating enzymes
are the deubiquitylating enzymes (DUBs). These cysteine or metal-
lo-proteases cleave ubiquitin from linear ubiquitin polypeptides or
from speciﬁc mono- or polyubiquitylated substrates and are
responsible for processing inactive ubiquitin precursors, proof-
reading ubiquitin-protein conjugates, and removing and recycling
ubiquitin from cellular adducts [3]. Cysteine protease DUBs are
organized into four subclasses based on their ubiquitin-protease
domains: ubiquitin-speciﬁc protease (USP), ubiquitin C-terminal
hydrolase (UCH), Otubain protease (OTU), and Machado-Joseph
disease protease (MJD). The metallo-protease DUBs belong to the
Jab1/Mov34/Mpr1 Pad1N-terminal+ (MPN+) (JAMM) domain
superfamily.
To date, numerous cellular targets of ubiquitin have been iden-
tiﬁed [4–10]. In this review, we focus on the ubiquitylation and
deubiquitylation of Proliferating Cell Nuclear Antigen (PCNA), a
homotrimeric ring that functions as a DNA polymerase sliding
clamp accessory protein as well as a scaffold for numerous proteins
involved in DNA replication, repair, cell cycle regulation, and chro-
matin assembly. We review the importance of PCNA ubiquitylation
and deubiquitylation in the DNA damage response, with special
emphasis on DNA damage bypass following replication stress.Fin-
ally, we will discuss the coordinated activities of ubiquitin speciﬁc
protease 1 (USP1) and the newly identiﬁed function of Enhanced
Level of Genome Instability Gene 1 (ELG1) as a regulator of PCNA
ubiquitylation.ochemical Societies.
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2.1. DNA damage bypass
Replication stress can arise from both endogenous metabolic
processes and exogenous DNA damaging agents and can interfere
with the progression of the DNA replication fork. For example,
UV light promotes the formation of cyclobutane pyrimidine dimers
that alter the structure of DNA and consequently inhibit DNA poly-
merases, and hydroxyurea depletes nucleotide pools thereby halt-
ing DNA synthesis. Failure to relieve such DNA replication stress
can have dire consequences for the cell, as stalled replication forks
are prone to collapse and could potentially lead to double-strand
breaks (DSBs) that result in cell death, or to gross chromosomal
rearrangements that have a close link to tumorigenesis. To prevent
such a situation, cells have evolved a mode of DNA damage bypass
termed post-replication repair (PRR). Although PRR does not re-
move the actual lesion from DNA, it does enable the cell cycle to
safely progress from the S to G2 phase, where damage can then
be repaired by appropriate DNA repair pathways including base
excision repair, nucleotide excision repair, or homologous recom-
bination repair. PRR can be divided into two distinct pathways:
translesion synthesis (TLS) and template switching. Whereas the
latter bypass is thought to utilize the genetic information encoded
by the newly synthesized, undamaged sister chromatid to carry
out a recombination-mediated mechanism, TLS employs special-
ized, DNA damage-tolerant polymerases that can synthesize DNA
directly across the damaged template. As discussed below, the
post-translational modiﬁcation of PCNA by ubiquitin and the small
ubiquitin-like modiﬁer (SUMO) plays a key role in deciding which
of these pathways is used for the processing of DNA lesions that
arise during replication.
2.2. PCNA monoubiquitylation
Following DNA damage that stalls the progression of the DNA
replication fork, the highly conserved K164 of PCNA is monoubiq-
uitylated by the E2 Rad6 and the E3 Rad18 (Fig. 1) [11]. PCNAFig. 1. PCNA modiﬁcations occur following DNA replication stress. In response to DNA
(SUMO) by Ubc9/Siz1 or monoubiquitylated (Ub) by Rad6/Rad18. The former modiﬁcatio
and the latter attracts specialized polymerases that carry out translesion synthesis. K164
template switching by a currently unknown mechanism. PCNA SUMOylation and ubiquit
USP1/ELG1.monoubiquitylation has been reported in a wide variety of organ-
isms including yeast, Xenopus, chicken, and mammals. The trigger
for DNA damage-induced PCNA monoubiquitylation is believed to
result from the uncoupling of the stalled replicative polymerase
and the MCM helicase, which results in production of single-
stranded DNA exposed in the vicinity of the stalled fork. This sin-
gle-stranded DNA is coated by Replication Protein A (RPA), which
in turn interacts with Rad18 and directs the Rad6/Rad18 complex
to the site of DNA damage [12,13]. Consistent with this model,
there are data demonstrating that Rad18 and RPA physically inter-
act, the siRNA-mediated depletion of RPA2 in human cells results
in a moderate reduction in damage-induced PCNA ubiquitylation,
and a RPA-coated immobilized oligonucleotide can recruit Rad6/
Rad18 [13–15]. In in vitro reactions, RPA appears to be dispensable
for PCNA modiﬁcation, although this could be explained by the
high concentration of conjugation factors present in the reaction
[14,16]. The direct binding of Rad18 to DNA appears to be impor-
tant for PCNA monoubiquitylation [13]. However, since the
in vitro afﬁnity of the Rad6/Rad18 complex for single-standed
DNA is highly dependent on salt concentration, the physiological
relevance of the direct binding of Rad18 to DNA is still controver-
sial [14].
Since RPA-bound single-stranded DNA is thought to initiate the
ATR-Chk1 DNA damage checkpoint pathway [17], several studies
have been conducted to investigate the relationship between PCNA
monoubiquitylation and the activation of the S phase checkpoint.
Although one such study demonstrated that the siRNA-mediated
knockdown of ATR and the overexpression of an inactive Chk1 sig-
niﬁcantly reduced PCNA ubiquitylation upon exposure to the DNA
adduct benzo[a]pyrene dihydrodiol epoxide (BDPE) [18], the re-
sults from several other experiments indicate that PCNA ubiquity-
lation occurs independently of checkpoint activation following
DNA damage [13,19–22]. One notable exception is PCNA monoub-
iquitylation at K107, which was recently shown to be a prerequi-
site for checkpoint activation in DNA ligase I-deﬁcient cells [23].
Once monoubiquitylated at K164, PCNA recruits members of
the Y-family TLS polymerases (Polg, Polj, Poli, and REV1) as well
as the B-family TLS polymerase Polf to the site of DNA damagedamage stalling the DNA replication fork, K164 of PCNA can either be SUMOylated
n inhibits inappropriate homologous recombination by recruiting the helicase Srs2,
monoubiquitylation can also be further extended by Ubc13/Mms2/Rad5 to initiate
ylation are both reversible – SUMO is removed by ULP1 and ubiquitin is removed by
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PCNA through their UBM or UBZ ubiquitin-binding domains as well
as through their PCNA interacting peptide (PIP) motifs. The prefer-
ential binding of the TLS polymerases to monoubiquitylated PCNA
enables the TLS polymerases to replace the stalled replicative DNA
polymerase (Pold or Pole) at the blocked sites of the DNA replica-
tion fork [24–29]. In contrast to the replicative polymerases, the
TLS polymerases have large open active sites that can accommo-
date bulky DNA lesions. Consequently, the TLS polymerases have
the ability to bypass DNA adducts without removing the actual le-
sion [30]. Whereas some TLS polymerases, such as Polg, can by-
pass DNA damage in a fairly error-free fashion [31–33], others,
such as Polf, exhibit low ﬁdelity when bypassing DNA damage
and result in elevated mutagenesis [34]. The physiological impor-
tance of TLS is highlighted by the discovery that a mutation in
the human POLH gene encoding Polg is responsible for the variant
form of the skin cancer-prone syndrome Xeroderma Pigmentosum
[31,32].
2.3. PCNA polyubiquitylation
In many organisms including budding yeast, S. cerevisiae, K164
monoubiquitylation can be further polyubiquitylated by the E2/E2
variant Ubc13/Mms2 and the E3 Rad5 (Fig. 1). Ubc13/Mms2 is re-
cruited from the cytoplasm to the site of the DNA lesion through
the RING ﬁnger domain of Rad5, and Rad5 is recruited to the
stalled fork through interaction with Rad18 [11,35]. The coordi-
nated enzymatic activities of Ubc13/Mms2 and Rad5 generate a
polyubiquitylated chain linked through the K63 residue of ubiqui-
tin [36,37]. The addition of this chain activates the template
switching mechanism of DNA damage bypass (Fig. 1) by dislodging
TLS polymerases from PCNA, preventing the interaction of the TLS
polymerses with PCNA, or recruiting factors that carry out tem-
plate switching processes [38]. Unlike TLS, template switching
seems to be error-free. In fact, epistatic analyses in yeast revealed
that loss of the template switching mechanism results in increased
mutagenesis, presumably due to an increased reliance on the more
error-prone TLS for lesion bypass [39–42]. The mechanism of tem-
plate switching is still poorly understood due to the transient nat-
ure of the intermediates formed and the current inability to
identify many of the genes directly involved in the process but it
is known to require the helicase activity of Rad5 [43]. Although still
the subject of debate, it has been hypothesized that template
switching proceeds by a ‘‘chicken foot’’ mechanism. In this model,
Rad5 unwinds and anneals the nascent and template strands, and
subsequent fork regression activity produces a four-way junction
intermediate resembling a ‘‘chicken foot.’’ DNA polymerase then
extends the 30 end of the leading nascent strand by copying from
the nascent lagging strand, and the regression of the four-way
junction completes error-free replication through the DNA dam-
age. In a second model, a homologous recombination-like mecha-
nism occurs whereby the sister duplex is invaded by a single-
stranded gap, forming a D-loop [11,41].
There is increasing evidence that PCNA polyubiquitylation also
exists in mammalian systems, although it occurs at much lower
levels than monoubiquitylation and is only readily detectible after
over-expression of the relevant E3s [41,44]. RAD18 and UBC13 are
required for PCNA polyubiquitylation in human cells, but MMS2
appears to be dispensable [45]. Recently, HLTF and SHPRH were
identiﬁed as putative mammalian homologues of yeast Rad5. Both
proteins interact with RAD6/RAD18 and UBC13/MMS2 and pro-
mote the polyubiquitylation of PCNA [44,46–48]. However, hltf/
shprh double mutant mouse embryonic ﬁbroblasts (MEFs) are still
able to polyubiquitylate PCNA, suggesting the existence of an alter-
native E3 ligase [49].So what triggers the switch from PCNA monoubiquitylation to
polyubiquitylation (and by extension the switch from TLS to tem-
plate switching)? Although the answer to this question is not to-
tally clear, the level of DNA damage is thought to play a role,
since polyubiquitylation is observed following treatment with
increasing amounts of DNA damaging agents [48] and with
increasing amounts of RPA-coated single-stranded DNA [21]. It
has been suggested that an elevation in the amount of RPA-coated
single-stranded DNA results in a concomitant increase in RPA-
bound Rad18, and a subsequent decrease in Rad18 homodimeriza-
tion. Since Rad5 interacts with Rad18 at the same site at which
homodimerization occurs, Rad5 would then be able to better com-
pete for binding to Rad18 and would thus promote polyubiquityla-
tion of PCNA [38].
2.4. PCNA SUMOylation
In addition to ubiquitin, PCNA can be covalently modiﬁed by
SUMO following replication stress or during S phase in the absence
of DNA damage. PCNA SUMOylation occurs in an enzymatic cas-
cade that is analogous to that involved in ubiquitylation. PCNA is
SUMOylated at K164 and K127 by the E2 Ubc9 and the E3 Siz1
[11,50]. In S. cerevisiae, SUMOylated PCNA recruits the helicase
Srs2 through a conserved SUMO-interaction motif in the car-
boxy-terminus of Srs2 [51]. Recruitment of Srs2 disrupts Rad51
single-stranded ﬁlaments [52], thereby preventing inappropriate
homologous recombination [53]. When this occurs at a stalled rep-
lication fork, the inhibition of recombination by Srs2 allows for the
processing of lesions by ubiquitin-dependent TLS or template
switching [16,54–56] (Fig. 1). PCNA SUMOylation also assists
recombination-dependent gross chromosomal rearrangement
[57]. The SUMOylation of PCNA is a reversible modiﬁcation that
can be removed by the SUMO protease Ubl-speciﬁc protease 1
(ULP1) (Fig. 1).
In addition to S. cerevisiae, PCNA SUMOylation has also been
shown to occur in X. laevis egg extracts and chicken DT40 cells
[58–60]. Given that none of the Srs2-like helicases in X. laevis egg
extracts and chicken DT40 cells are known to exert an effect on
the Rad6 pathway, it is likely that PCNA SUMOylation in these
organisms functions in a different manner than PCNA SUMOylation
in yeast [14]. Modiﬁcation of PCNA by SUMO has yet to be reported
in human cells [49].
3. The deubiquitylation of PCNA as a safeguard against error-
prone TLS
USP1 was identiﬁed in a siRNA screen as a DUB responsible for
the deubiquitylation of PCNA following DNA damage bypass [61].
USP1 is also involved in the deubiquitylation of FANCD2, a Fanconi
anemia effector protein that functions in the repair of DNA inter-
strand crosslinks [62]. Considering the opposing roles of the E1/
E2/E3 ubiquitinating enzymes and the DUBs, it is not surprising
that exposure to UV light, which promotes PCNA monoubiquityla-
tion, also decreases USP1 protein levels. The mechanism for this
decrease involves an autocleavage event followed by proteasomal
degredation of the cleaved products. The ubiquitylation of PCNA
following replication stress is not always accompanied by the dis-
appearance of USP1, though. For example, treatment with
hydroxyurea (HU) results in no detectable change in USP1. To ex-
plain this phenomenon, it has been suggested that HU disrupts
the interaction between USP1 and its activating partner protein
UAF1 (USP1-associated factor 1) [12,61].
The importance of PCNA deubiquitylation is highlighted by the
ﬁnding that depletion of USP1 increases the level of mutagenesis
in the cell [61]. It is thought that persistent PCNA ubiquitylation
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polymerases and allows the error-prone TLS polymerases to repli-
cate undamaged DNA [61]. Even Polg, which can faithfully repli-
cate past UV-induced cyclobutane pyrimidine dimers, exhibits
much lower ﬁdelity compared to replicative polymerases when
copying undamaged DNA [63], and would thus contribute to in-
creased mutagenesis if used inappropriately. Such mutations
could ultimately disrupt basic cellular processes and/or cause
uncontrolled proliferation, the latter of which is a hallmark of can-
cer. In addition to being more error-prone than the replicative
DNA polymerases, the TLS polymerases also catalyze DNA synthe-
sis much more slowly and thus could potentially cause replication
fork collapse. As discussed above, collapsed replication forks are
particularly dangerous to cells, as they often result in genomic
instability.
Insights into the possible physiological consequences of defects
in PCNA deubiquitylation come from a USP1 transgenic mouse
model. Usp1/ mice displayed an increase in both FANCD2 and
PCNA monoubiquitylation, and exhibited a high rate of perinatal
lethality, depletion of male germ cells, infertility, hypersensitivity
to the crosslinking agent mitomycin C, and chromosome instabil-
ity. Usp1/ mice were also much smaller in size than their wild-
type littermates [64]. It remains to be determined whether these
mice exhibit increased point mutation frequency and increased
cancer incidence as would be expected given the in vitro data de-
scribed above.Fig. 2. A model for the role of ELG1 in PCNA deubiquitylation. Upon encountering
DNA damage, the replication machinery becomes stalled. PCNA is then monoub-
iquitylated, and a TLS polymerase is recruited to the damage site to replace the
replicative polymerase (Pold/e) and bypass the lesion. Once bypass has occurred,
ELG1, which becomes concentrated at stalled forks with distinct foci structures in
the nucleus, binds to PCNA and recruits the USP1/UAF1 complex. USP1 deubiqui-
tylates PCNA, displacing the TLS polymerase and allowing Pold/e to resume normal
replication.4. ELG1 and its role in the deubiquitylation of PCNA
4.1. ELG1 and the RFC complex
The loading and unloading of PCNA on DNA is carried out by
an ATP-dependent Replication Factor C (RFC) complex. The
canonical RFC complex consists of 5 subunits, RFC 1–5. There also
exist three alternative RFC complexes in which RFC1 is replaced
by either CTF18, RAD17, or ELG1. The canonical RFC loads PCNA
onto DNA during general DNA replication [65]. CTF18-RFC un-
loads PCNA from DNA where sister chromatids are held by a
cohesion complex [66], and has recently been implicated in the
replication fork bypass of lesions that arise from triplet repeats
[67] and in S-phase checkpoint activation [68,69]. RAD17-RFC
loads the PCNA-like 9-1-1 complex (consisting of RAD9, RAD1,
and HUS1) onto damaged DNA for activation of the DNA damage
checkpoint [70].
Initially, the role of the ELG1-RFC complex was not clearly
understood, even though it was known to play an important part
in the suppression of gross chromosomal rearrangements and the
maintenance of genomic stability during normal cell growth [71–
75]. However, studies in yeast soon brought forth several possi-
bilities [76]. The ﬁrst was that ELG1-RFC functions as a clamp
loader during DNA replication. Although this hypothesis was sup-
ported by ELG1’s interaction with PCNA and the ﬂap endonucle-
ase Rad27 (yeast FEN1) [73], PCNA loading or unloading by ELG1-
RFC could not be detected in vitro. ELG1’s interaction with PCNA
and its colocalization with Polg also raised the possibility that
ELG1-RFC could serve as a platform for polymerase switching
during TLS. Alternatively, because ELG1 and template switching
both suppress gross chromosomal rearrangements, it was easy
to envision a role for ELG1 in the error-free mode of DNA damage
bypass. Finally, it was suggested that ELG1-RFC functions in chro-
matin assembly through PCNA interaction. Evidence for this came
from the synthetic lethality between elg1 and the htb1 or bre11
mutants that create defects in histone levels and histone modiﬁ-
cation [77].4.2. ELG1 as a regulator of PCNA ubiquitylation
Last year, great strides were made in understanding the func-
tional signiﬁcance of ELG1 when it was discovered that the human
homolog of ELG1 (which is also called ATAD5) not only interacts
with PCNA and colocalizes with the sliding clamp at stalled repli-
cation forks with distinct foci structures in the nucleus, but also
associates with the USP1-UAF1 complex. This observation led to
the hypothesis that ELG1 affects the deubiquitylation of PCNA
(Fig. 2). Indeed, the siRNA-mediated knockdown of ELG1 resulted
in an increase in PCNA monoubiquitylation that could be rescued
by ectopic expression of siRNA-resistant ELG1. The regulation of
PCNA ubiquitylation was speciﬁc to ELG1 and vice versa, as the
knockdown of CTF18 and RAD17 did not increase PCNA ubiquityla-
tion and the knockdown of ELG1 did not affect the ubiquitylation
of USP1’s other target protein FANCD2. The knockdown of RFC1
or RFC4 also did not increase PCNA ubiquitylation, suggesting that
this function of ELG1 is independent of its role as an alternative
RFC complex [78].
How does ELG1 down-regulate PCNA ubiquitylation? One pos-
sibility is that ELG1 modulates the expression or stability of
USP1. However, no detectable changes in USP1 protein levels were
observed following ELG1 knockdown. The second possibility is that
ELG1 enhances or stabilizes the interaction between USP1 and its
activating factor UAF1. This scenario is also unlikely, considering
that the ability of USP1 to interact with UAF1 remained unchanged
in ELG1-knockdown cells. Finally, ELG1 could regulate USP1 activ-
ity or recruit USP1-UAF1 to monoubiquitylated PCNA. In support of
this theory, a synergistic reduction in UV-induced PCNA monoub-
iquitylation was observed following the overexpression of both
ELG1 and USP1. Additionally, the overexpression of USP1 alone
had no effect on PCNA monoubiquitylation in the absence of
ELG1, indicating that ELG1 is required for the deubiquitylation of
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sient because ELG1 knockdown did not affect the levels of USP1
bound to chromatin, and in contrast to ELG1, neither USP1 nor
UAF1 formed foci following DNA damage [78].
Unlike the observation in human cells, the knockout of the ELG1
gene in S. cerevisiae caused a higher level of chromatin-bound
SUMOylated PCNA [79]. The SUMO-interacting domain of yeast
Elg1 appears to be important for the interaction between Elg1
and PCNA and for regulating chromatin-bound SUMOylated PCNA.
Since SUMOylated PCNA inhibits homologous recombination
[55,56], and elg1 mutation is synthetic lethal with genes involved
in homologous recombination [77], yeast Elg1 might function to
reduce the level of SUMOylated PCNA in chromatin. However,
the fact that elg1 mutation generates a hyper-recombination phe-
notype [72,80], hints at further complexity regarding the genetic
interaction between ELG1 and SUMOylated PCNA. It is also still un-
clear whether Elg1-RFC actively unloads SUMOylated PCNA from
chromatin or recruits the deSUMOylating enzyme Ulp1 to chroma-
tin to reduce the level of SUMOylated PCNA. Due to the absence of
SUMOylated PCNA (at least in published literature), it is unclear if
there is a similar mechanism conserved in mammalian systems
[49].
As discussed above, PCNA deubiquitylation plays an important
role in preventing TLS polymerases with low ﬁdelity and processiv-
ity from replicating undamaged DNA, a process that could result in
mutagenesis, DSBs, and gross chromosomal rearrangements. Con-
sistent with the proposed role for ELG1 in the USP1-UAF1-medi-
ated deubiquitylation of PCNA, ELG1 knockdown cells display a
signiﬁcant increase in mutation frequency [78], a higher incidence
of chromosome end-to-end fusions, inversions and aneuploidy
[81], and an increase in the foci formation of the DSB markers
cH2AX, 53BP1, and phospho-ATM [81]. Elg1+/ MEFs, which dis-
play an increase in the levels of chromatin-bound PCNA compared
to wildtype MEFs, also exhibit genomic instability and spontane-
ous DNA damage. Furthermore, Elg1+/mice develop a wide variety
of tumors displaying genomic instability and die between 11 and
18 months of age (Myung lab, unpublished results).
5. Conclusion
Much progress has been made in understanding the regulation
of PCNA ubiquitylation and its role in DNA damage bypass and the
maintenance of genomic integrity. We now know that K164
monoubiquitylation by RAD6/RAD18 functions to recruit the Y-
family DNA polymerases and activate TLS, whereas further exten-
sion of this modiﬁcation by UBC13/MMS2/RAD5 initiates an er-
ror-free template switching mechanism. PCNA SUMOylation can
also occur at the same residue as ubiquitylation and serves to sup-
press homologous recombination at the site of the stalled replica-
tion fork through the recruitment of Srs2. Equally important as
PCNA ubiquitylation is PCNA deubiquitylation, which is carried
out by the USP1-UAF1 complex in conjunction with ELG1. ELG1
speciﬁcally directs the USP1-UAF1 to PCNA at the damage site,
and in doing so initiates the switch from the error-prone and
poorly processive TLS polymerases to the faithful replicative poly-
merases Pold and Pole. Such a switch is necessary to reduce the
likelihood of mutagenic effects by the TLS polymerases following
DNA damage bypass.
Despite the signiﬁcant advancements made, many questions
still remain. For example, exactly when does DNA damage bypass
occur? What are the conditions under which the template switch-
ing mode of PRR is activated in favor of TLS? What is the mecha-
nism of template switching? And what regulates USP1 activity
when the protein is not actively degraded following DNA damage?
Future studies addressing these issues will provide more detailedinsight into the pathways in which PCNA ubiquitylation/deubiqui-
tylation function, and further highlight the importance of these
modiﬁcations in the maintenance of genomic integrity.
Acknowledgments
We thank A. D’Andrea (Dana Faber Cancer Institute), J. McCulley
(NHGRI, NIH) and R. Woodgate (NICHD, NIH) for helpful discus-
sions and comments on the manuscript; K.M. especially thanks E.
Cho. This research was supported by the intramural research pro-
gram of the NHGRI, NIH to K.M.
References
[1] Friedberg, E.C. (2006) Reversible monoubiquitination of PCNA: a novel slant on
regulating translesion DNA synthesis. Mol. Cell 22, 150–152.
[2] Ikeda, F. and Dikic, I. (2008) Atypical ubiquitin chains: new molecular signals.
‘Protein Modiﬁcations: Beyond the Usual Suspects’ review series. EMBO Rep. 9,
536–542.
[3] Amerik, A.Y. and Hochstrasser, M. (2004) Mechanism and function of
deubiquitinating enzymes. Biochim. Biophys. Acta 1695, 189–207.
[4] Campanero, M.R. and Flemington, E.K. (1997) Regulation of E2F through
ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor
suppressor protein. Proc. Natl. Acad. Sci. USA 94, 2221–2226.
[5] de Graaf, P., Little, N.A., Ramos, Y.F., Meulmeester, E., Letteboer, S.J. and
Jochemsen, A.G. (2003) Hdmx protein stability is regulated by the ubiquitin
ligase activity of Mdm2. J. Biol. Chem. 278, 38315–38324.
[6] Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H. and Weissman, A.M. (2000)
Mdm2 is a RING ﬁnger-dependent ubiquitin protein ligase for itself and p53. J.
Biol. Chem. 275, 8945–8951.
[7] Isobe, T., Uchida, C., Hattori, T., Kitagawa, K., Oda, T. and Kitagawa, M. (2006)
Ubiquitin-dependent degradation of adenovirus E1A protein is inhibited by
BS69. Biochem. Biophys. Res. Commun. 339, 367–374.
[8] Suzuki, H., Chiba, T., Kobayashi, M., Takeuchi, M., Furuichi, K. and Tanaka, K.
(1999) In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to
IkappaBalpha phosphorylated by IKK, leading to ubiquitination. Biochem.
Biophys. Res. Commun. 256, 121–126.
[9] Suzuki, Y., Nakabayashi, Y. and Takahashi, R. (2001) Ubiquitin-protein ligase
activity of X-linked inhibitor of apoptosis protein promotes proteasomal
degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced
cell death. Proc. Natl. Acad. Sci. USA 98, 8662–8667.
[10] Uchida, C. et al. (2005) Enhanced Mdm2 activity inhibits pRB function via
ubiquitin-dependent degradation. EMBO J. 24, 160–169.
[11] Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G. and Jentsch, S. (2002)
RAD6-dependent DNA repair is linked to modiﬁcation of PCNA by ubiquitin
and SUMO. Nature 419, 135–141.
[12] Brown, S., Niimi, A. and Lehmann, A.R. (2009) Ubiquitination and
deubiquitination of PCNA in response to stalling of the replication fork. Cell
Cycle 8, 689–692.
[13] Davies, A.A., Huttner, D., Daigaku, Y., Chen, S. and Ulrich, H.D. (2008)
Activation of ubiquitin-dependent DNA damage bypass is mediated by
replication protein a. Mol. Cell 29, 625–636.
[14] Ulrich, H.D. (2009) Regulating post-translational modiﬁcations of the
eukaryotic replication clamp PCNA. DNA Rep. (Amst.) 8, 461–469.
[15] Huttner, D. and Ulrich, H.D. (2008) Cooperation of replication protein A with
the ubiquitin ligase Rad18 in DNA damage bypass. Cell Cycle 7, 3629–3633.
[16] Haracska, L., Torres-Ramos, C.A., Johnson, R.E., Prakash, S. and Prakash, L.
(2004) Opposing effects of ubiquitin conjugation and SUMO modiﬁcation of
PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae.
Mol. Cell Biol. 24, 4267–4274.
[17] Zou, L. (2007) Single- and double-stranded DNA: building a trigger of ATR-
mediated DNA damage response. Genes Dev. 21, 879–885.
[18] Bi, X., Barkley, L.R., Slater, D.M., Tateishi, S., Yamaizumi, M., Ohmori, H. and
Vaziri, C. (2006) Rad18 regulates DNA polymerase kappa and is required for
recovery from S-phase checkpoint-mediated arrest. Mol. Cell Biol. 26, 3527–
3540.
[19] Niimi, A., Brown, S., Sabbioneda, S., Kannouche, P.L., Scott, A., Yasui, A., Green,
C.M. and Lehmann, A.R. (2008) Regulation of proliferating cell nuclear antigen
ubiquitination in mammalian cells. Proc. Natl. Acad. Sci. USA 105, 16125–
16130.
[20] Brun, J., Chiu, R.K., Wouters, B.G. and Gray, D.A. (2010) Regulation of PCNA
polyubiquitination in human cells. BMC Res. Notes 3, 85.
[21] Chang, D.J., Lupardus, P.J. and Cimprich, K.A. (2006) Monoubiquitination of
proliferating cell nuclear antigen induced by stalled replication requires
uncoupling of DNA polymerase and mini-chromosome maintenance helicase
activities. J. Biol. Chem. 281, 32081–32088.
[22] Frampton, J. et al. (2006) Postreplication repair and PCNA modiﬁcation in
Schizosaccharomyces pombe. Mol. Biol. Cell 17, 2976–2985.
[23] Das-Bradoo, S., Nguyen, H.D., Wood, J.L., Ricke, R.M., Haworth, J.C. and
Bielinsky, A.K. (2010) Defects in DNA ligase I trigger PCNA ubiquitylation at
Lys 107. Nat. Cell Biol. 12, 74–79. sup pp. 1–20.
J.T. Fox et al. / FEBS Letters 585 (2011) 2780–2785 2785[24] Bienko, M. et al. (2005) Ubiquitin-binding domains in Y-family polymerases
regulate translesion synthesis. Science 310, 1821–1824.
[25] Friedberg, E.C., Lehmann, A.R. and Fuchs, R.P. (2005) Trading places: how do
DNA polymerases switch during translesion DNA synthesis? Mol. Cell 18,
499–505.
[26] Kannouche, P.L. and Lehmann, A.R. (2004) Ubiquitination of PCNA and the
polymerase switch in human cells. Cell Cycle 3, 1011–1013.
[27] Kannouche, P.L., Wing, J. and Lehmann, A.R. (2004) Interaction of human DNA
polymerase eta with monoubiquitinated PCNA: a possible mechanism for the
polymerase switch in response to DNA damage. Mol. Cell 14, 491–500.
[28] Plosky, B.S., Vidal, A.E., Fernandez de Henestrosa, A.R., McLenigan, M.P.,
McDonald, J.P., Mead, S. and Woodgate, R. (2006) Controlling the subcellular
localization of DNA polymerases iota and eta via interactions with ubiquitin.
EMBO J. 25, 2847–2855.
[29] Watanabe, K., Tateishi, S., Kawasuji, M., Tsurimoto, T., Inoue, H. and
Yamaizumi, M. (2004) Rad18 guides poleta to replication stalling sites
through physical interaction and PCNA monoubiquitination. EMBO J. 23,
3886–3896.
[30] Yang, W. and Woodgate, R. (2007) What a difference a decade makes: insights
into translesion DNA synthesis. Proc. Natl. Acad. Sci. USA 104, 15591–15598.
[31] Johnson, R.E., Prakash, S. and Prakash, L. (1999) Efﬁcient bypass of a thymine-
thymine dimer by yeast DNA polymerase, Poleta. Science 283, 1001–1004.
[32] Masutani, C., Araki, M., Yamada, A., Kusumoto, R., Nogimori, T., Maekawa, T.,
Iwai, S. and Hanaoka, F. (1999) Xeroderma pigmentosum variant (XP-V)
correcting protein from HeLa cells has a thymine dimer bypass DNA
polymerase activity. EMBO J. 18, 3491–3501.
[33] Masutani, C. et al. (1999) The XPV (xeroderma pigmentosum variant) gene
encodes human DNA polymerase eta. Nature 399, 700–704.
[34] Lin, W., Wu, X. and Wang, Z. (1999) A full-length cDNA of hREV3 is predicted
to encode DNA polymerase zeta for damage-induced mutagenesis in humans.
Mutat. Res. 433, 89–98.
[35] Ulrich, H.D. and Jentsch, S. (2000) Two RING ﬁnger proteins mediate
cooperation between ubiquitin-conjugating enzymes in DNA repair. EMBO J.
19, 3388–3397.
[36] Brusky, J., Zhu, Y. and Xiao, W. (2000) UBC13, a DNA-damage-inducible gene,
is a member of the error-free postreplication repair pathway in
Saccharomyces cerevisiae. Curr. Genet. 37, 168–174.
[37] Hofmann, R.M. and Pickart, C.M. (1999) Noncanonical MMS2-encoded
ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin
chains for DNA repair. Cell 96, 645–653.
[38] Chang, D.J. and Cimprich, K.A. (2009) DNA damage tolerance. when it’s OK to
make mistakes. Nat. Chem. Biol. 5, 82–90.
[39] Broomﬁeld, S., Chow, B.L. and Xiao, W. (1998) MMS2, encoding a ubiquitin-
conjugating-enzyme-like protein, is a member of the yeast error-free
postreplication repair pathway. Proc. Natl. Acad. Sci. USA 95, 5678–5683.
[40] Broomﬁeld, S., Hryciw, T. and Xiao, W. (2001) DNA postreplication repair and
mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 486, 167–184.
[41] Chiu, R.K., Brun, J., Ramaekers, C., Theys, J., Weng, L., Lambin, P., Gray, D.A. and
Wouters, B.G. (2006) Lysine 63-polyubiquitination guards against translesion
synthesis-induced mutations. PLoS Genet. 2, e116.
[42] Xiao, W., Chow, B.L., Broomﬁeld, S. and Hanna, M. (2000) The Saccharomyces
cerevisiae RAD6 group is composed of an error-prone and two error-free
postreplication repair pathways. Genetics 155, 1633–1641.
[43] Blastyak, A., Pinter, L., Unk, I., Prakash, L., Prakash, S. and Haracska, L. (2007)
Yeast Rad5 protein required for postreplication repair has a DNA helicase
activity speciﬁc for replication fork regression. Mol. Cell 28, 167–175.
[44] Motegi, A., Sood, R., Moinova, H., Markowitz, S.D., Liu, P.P. and Myung, K.
(2006) Human SHPRH suppresses genomic instability through proliferating
cell nuclear antigen polyubiquitination. J. Cell Biol. 175, 703–708.
[45] Brun, J., Chiu, R., Lockhart, K., Xiao, W., Wouters, B.G. and Gray, D.A. (2008)
HMMS2 serves a redundant role in human PCNA polyubiquitination. BMCMol.
Biol. 9, 24.
[46] Unk, I., Hajdu, I., Fatyol, K., Hurwitz, J., Yoon, J.H., Prakash, L., Prakash, S. and
Haracska, L. (2008) Human HLTF functions as a ubiquitin ligase for
proliferating cell nuclear antigen polyubiquitination. Proc. Natl. Acad. Sci.
USA 105, 3768–3773.
[47] Unk, I. et al. (2006) Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-
dependent polyubiquitylation of proliferating cell nuclear antigen. Proc. Natl.
Acad. Sci. USA 103, 18107–18112.
[48] Motegi, A. et al. (2008) Polyubiquitination of proliferating cell nuclear antigen
by HLTF and SHPRH prevents genomic instability from stalled replication
forks. Proc. Natl. Acad. Sci. USA 105, 12411–12416.
[49] Krijger, P.H. et al. (2011) HLTF and SHPRH are not essential for PCNA
polyubiquitination, survival and somatic hypermutation: existence of an
alternative E3 ligase. DNA Rep 10, 438–444.
[50] Stelter, P. and Ulrich, H.D. (2003) Control of spontaneous and damage-induced
mutagenesis by SUMO and ubiquitin conjugation. Nature 425, 188–191.
[51] Kerscher, O. (2007) SUMO junction-what’s your function? New insights
through SUMO-interacting motifs. EMBO Rep. 8, 550–555.
[52] Branzei, D. and Foiani, M. (2007) RecQ helicases queuing with Srs2 to disrupt
Rad51 ﬁlaments and suppress recombination. Genes Dev. 21, 3019–3026.
[53] Branzei, D. et al. (2006) Ubc9- and mms21-mediated sumoylation counteracts
recombinogenic events at damaged replication forks. Cell 127, 509–522.[54] Branzei, D., Vanoli, F. and Foiani, M. (2008) SUMOylation regulates Rad18-
mediated template switch. Nature 456, 915–920.
[55] Papouli, E., Chen, S., Davies, A.A., Huttner, D., Krejci, L., Sung, P. and Ulrich, H.D.
(2005) Crosstalk between SUMO and ubiquitin on PCNA is mediated by
recruitment of the helicase Srs2p. Mol. Cell 19, 123–133.
[56] Pfander, B., Moldovan, G.L., Sacher, M., Hoege, C. and Jentsch, S. (2005) SUMO-
modiﬁed PCNA recruits Srs2 to prevent recombination during S phase. Nature
436, 428–433.
[57] Motegi, A., Kuntz, K., Majeed, A., Smith, S. and Myung, K. (2006) Regulation of
gross chromosomal rearrangements by ubiquitin and SUMO ligases in
Saccharomyces cerevisiae. Mol. Cell Biol. 26, 1424–1433.
[58] Arakawa, H., Moldovan, G.L., Saribasak, H., Saribasak, N.N., Jentsch, S. and
Buerstedde, J.M. (2006) A role for PCNA ubiquitination in immunoglobulin
hypermutation. PLoS Biol. 4, e366.
[59] Leach, C.A. and Michael, W.M. (2005) Ubiquitin/SUMO modiﬁcation of PCNA
promotes replication fork progression in Xenopus laevis egg extracts. J. Cell
Biol. 171, 947–954.
[60] Gohler, T., Munoz, I.M., Rouse, J. and Blow, J.J. (2008) PTIP/Swift is required for
efﬁcient PCNA ubiquitination in response to DNA damage. DNA Rep. (Amst.) 7,
775–787.
[61] Huang, T.T. et al. (2006) Regulation of monoubiquitinated PCNA by DUB
autocleavage. Nat. Cell Biol. 8, 339–347.
[62] Nijman, S.M., Huang, T.T., Dirac, A.M., Brummelkamp, T.R., Kerkhoven, R.M.,
D’Andrea, A.D. and Bernards, R. (2005) The deubiquitinating enzyme USP1
regulates the Fanconi anemia pathway. Mol. Cell 17, 331–339.
[63] Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F. and Kunkel, T.A. (2000) Low
ﬁdelity DNA synthesis by human DNA polymerase-eta. Nature 404, 1011–
1013.
[64] Kim, J.M., Parmar, K., Huang, M., Weinstock, D.M., Ruit, C.A., Kutok, J.L. and
D’Andrea, A.D. (2009) Inactivation of murine Usp1 results in genomic
instability and a Fanconi anemia phenotype. Dev. Cell 16, 314–320.
[65] Waga, S. and Stillman, B. (1998) The DNA replication fork in eukaryotic cells.
Annu. Rev. Biochem. 67, 721–751.
[66] Bylund, G.O. and Burgers, P.M. (2005) Replication protein A-directed
unloading of PCNA by the Ctf18 cohesion establishment complex. Mol. Cell
Biol. 25, 5445–5455.
[67] Gellon, L., Razidlo, D.F., Gleeson, O., Verra, L., Schulz, D., Lahue, R.S. and
Freudenreich, C.H. (2011) New functions of Ctf18-RFC in preserving genome
stability outside its role in sister chromatid cohesion. PLoS Genet. 7, e1001298.
[68] Kubota, T., Hiraga, S.I., Yamada, K., Lamond, A.I. and Donaldson, A.D. (2011).
Quantitative proteomic analysis of chromatin reveals that Ctf18 acts in the
DNA replication checkpoint. Mol Cell Proteom. [Epub ahead of print].
[69] Naiki, T., Kondo, T., Nakada, D., Matsumoto, K. and Sugimoto, K. (2001) Chl12
(Ctf18) forms a novel replication factor C-related complex and functions
redundantly with Rad24 in the DNA replication checkpoint pathway. Mol. Cell
Biol. 21, 5838–5845.
[70] Lindsey-Boltz, L.A., Bermudez, V.P., Hurwitz, J. and Sancar, A. (2001)
Puriﬁcation and characterization of human DNA damage checkpoint Rad
complexes. Proc. Natl. Acad. Sci. USA 98, 11236–11241.
[71] Bellaoui, M., Chang, M., Ou, J., Xu, H., Boone, C. and Brown, G.W. (2003) Elg1
forms an alternative RFC complex important for DNA replication and genome
integrity. EMBO J. 22, 4304–4313.
[72] Ben-Aroya, S., Koren, A., Liefshitz, B., Steinlauf, R. and Kupiec, M. (2003) ELG1,
a yeast gene required for genome stability, forms a complex related to
replication factor C. Proc. Natl. Acad. Sci. USA 100, 9906–9911.
[73] Kanellis, P., Agyei, R. and Durocher, D. (2003) Elg1 forms an alternative PCNA-
interacting RFC complex required to maintain genome stability. Curr. Biol. 13,
1583–1595.
[74] Smith, S., Hwang, J.Y., Banerjee, S., Majeed, A., Gupta, A. and Myung, K. (2004)
Mutator genes for suppression of gross chromosomal rearrangements
identiﬁed by a genome-wide screening in Saccharomyces cerevisiae. Proc.
Natl. Acad. Sci. USA 101, 9039–9044.
[75] Banerjee, S. and Myung, K. (2004) Increased genome instability and telomere
length in the elg1-deﬁcient Saccharomyces cerevisiae mutant are regulated by
S-phase checkpoints. Eukaryot. Cell 3, 1557–1566.
[76] Banerjee, S., Sikdar, N. and Myung, K. (2007) Suppression of gross
chromosomal rearrangements by a new alternative replication factor C
complex. Biochem. Biophys. Res. Commun. 362, 546–549.
[77] Aroya, S.B. and Kupiec, M. (2005) The Elg1 replication factor C-like complex: a
novel guardian of genome stability. DNA Rep. (Amst.) 4, 409–417.
[78] Lee, K.Y., Yang, K., Cohn, M.A., Sikdar, N., D’Andrea, A.D. and Myung, K. (2010)
Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear
antigen (PCNA) through Its interactions with PCNA and USP1. J. Biol. Chem.
285, 10362–10369.
[79] Parnas, O., Zipin-Roitman, A., Pfander, B., Liefshitz, B., Mazor, Y., Ben-Aroya, S.,
Jentsch, S. and Kupiec, M. (2010) Elg1, an alternative subunit of the RFC clamp
loader, preferentially interacts with SUMOylated PCNA. EMBO J. 29, 2611–
2622.
[80] Ogiwara, H., Ui, A., Enomoto, T. and Seki, M. (2007) Role of Elg1 protein in
double strand break repair. Nucleic Acids Res. 35, 353–362.
[81] Sikdar, N. et al. (2009) DNA damage responses by human ELG1 in S phase are
important to maintain genomic integrity. Cell Cycle 8, 3199–3207.
